nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxapram—Hypoxia—Fludarabine—lymphatic system cancer	0.048	0.048	CcSEcCtD
Doxapram—Respiratory failure—Fludarabine—lymphatic system cancer	0.031	0.031	CcSEcCtD
Doxapram—Phlebitis—Teniposide—lymphatic system cancer	0.0292	0.0292	CcSEcCtD
Doxapram—Phlebitis—Fludarabine—lymphatic system cancer	0.0257	0.0257	CcSEcCtD
Doxapram—Bronchospasm—Teniposide—lymphatic system cancer	0.0214	0.0214	CcSEcCtD
Doxapram—Respiratory failure—Vincristine—lymphatic system cancer	0.019	0.019	CcSEcCtD
Doxapram—Phlebitis—Bleomycin—lymphatic system cancer	0.0188	0.0188	CcSEcCtD
Doxapram—Sweating—Teniposide—lymphatic system cancer	0.0186	0.0186	CcSEcCtD
Doxapram—Leukopenia—Mechlorethamine—lymphatic system cancer	0.0184	0.0184	CcSEcCtD
Doxapram—Disorientation—Bleomycin—lymphatic system cancer	0.0181	0.0181	CcSEcCtD
Doxapram—Phlebitis—Carmustine—lymphatic system cancer	0.0164	0.0164	CcSEcCtD
Doxapram—Flushing—Teniposide—lymphatic system cancer	0.0162	0.0162	CcSEcCtD
Doxapram—Arrhythmia—Teniposide—lymphatic system cancer	0.0156	0.0156	CcSEcCtD
Doxapram—Phlebitis—Mitoxantrone—lymphatic system cancer	0.0153	0.0153	CcSEcCtD
Doxapram—Hypoxia—Methotrexate—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Doxapram—Agitation—Teniposide—lymphatic system cancer	0.0139	0.0139	CcSEcCtD
Doxapram—Bronchospasm—Bleomycin—lymphatic system cancer	0.0138	0.0138	CcSEcCtD
Doxapram—Arrhythmia—Fludarabine—lymphatic system cancer	0.0137	0.0137	CcSEcCtD
Doxapram—Leukopenia—Teniposide—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Doxapram—Chest pain—Teniposide—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Doxapram—Urinary retention—Vincristine—lymphatic system cancer	0.0128	0.0128	CcSEcCtD
Doxapram—Agitation—Fludarabine—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Doxapram—Hyperhidrosis—Teniposide—lymphatic system cancer	0.012	0.012	CcSEcCtD
Doxapram—Leukopenia—Fludarabine—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Doxapram—Pruritus—Mechlorethamine—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Doxapram—Cough—Fludarabine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Doxapram—Convulsion—Fludarabine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Doxapram—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Doxapram—Dyspnoea—Teniposide—lymphatic system cancer	0.011	0.011	CcSEcCtD
Doxapram—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Doxapram—Flushing—Bleomycin—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Doxapram—Sweating—Vincristine—lymphatic system cancer	0.00998	0.00998	CcSEcCtD
Doxapram—Nausea—Mechlorethamine—lymphatic system cancer	0.00997	0.00997	CcSEcCtD
Doxapram—Body temperature increased—Teniposide—lymphatic system cancer	0.00978	0.00978	CcSEcCtD
Doxapram—Paraesthesia—Fludarabine—lymphatic system cancer	0.00976	0.00976	CcSEcCtD
Doxapram—Hallucination—Carmustine—lymphatic system cancer	0.00974	0.00974	CcSEcCtD
Doxapram—Sweating—Mitoxantrone—lymphatic system cancer	0.00972	0.00972	CcSEcCtD
Doxapram—Dyspnoea—Fludarabine—lymphatic system cancer	0.00969	0.00969	CcSEcCtD
Doxapram—Hallucination—Vincristine—lymphatic system cancer	0.0093	0.0093	CcSEcCtD
Doxapram—Respiratory failure—Methotrexate—lymphatic system cancer	0.0092	0.0092	CcSEcCtD
Doxapram—Flushing—Carmustine—lymphatic system cancer	0.00909	0.00909	CcSEcCtD
Doxapram—Pruritus—Teniposide—lymphatic system cancer	0.00875	0.00875	CcSEcCtD
Doxapram—Arrhythmia—Carmustine—lymphatic system cancer	0.00875	0.00875	CcSEcCtD
Doxapram—Leukopenia—Bleomycin—lymphatic system cancer	0.00874	0.00874	CcSEcCtD
Doxapram—Body temperature increased—Fludarabine—lymphatic system cancer	0.00859	0.00859	CcSEcCtD
Doxapram—Cough—Bleomycin—lymphatic system cancer	0.00852	0.00852	CcSEcCtD
Doxapram—Diarrhoea—Teniposide—lymphatic system cancer	0.00846	0.00846	CcSEcCtD
Doxapram—Chest pain—Bleomycin—lymphatic system cancer	0.00832	0.00832	CcSEcCtD
Doxapram—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00813	0.00813	CcSEcCtD
Doxapram—Agitation—Carmustine—lymphatic system cancer	0.00783	0.00783	CcSEcCtD
Doxapram—Headache—Teniposide—lymphatic system cancer	0.00775	0.00775	CcSEcCtD
Doxapram—Pruritus—Fludarabine—lymphatic system cancer	0.00769	0.00769	CcSEcCtD
Doxapram—Leukopenia—Carmustine—lymphatic system cancer	0.00763	0.00763	CcSEcCtD
Doxapram—Agitation—Vincristine—lymphatic system cancer	0.00748	0.00748	CcSEcCtD
Doxapram—Diarrhoea—Fludarabine—lymphatic system cancer	0.00744	0.00744	CcSEcCtD
Doxapram—Convulsion—Carmustine—lymphatic system cancer	0.00739	0.00739	CcSEcCtD
Doxapram—Nausea—Teniposide—lymphatic system cancer	0.00735	0.00735	CcSEcCtD
Doxapram—Leukopenia—Vincristine—lymphatic system cancer	0.00728	0.00728	CcSEcCtD
Doxapram—Chest pain—Carmustine—lymphatic system cancer	0.00726	0.00726	CcSEcCtD
Doxapram—Anxiety—Carmustine—lymphatic system cancer	0.00723	0.00723	CcSEcCtD
Doxapram—Paraesthesia—Bleomycin—lymphatic system cancer	0.00716	0.00716	CcSEcCtD
Doxapram—Dyspnoea—Bleomycin—lymphatic system cancer	0.00711	0.00711	CcSEcCtD
Doxapram—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00709	0.00709	CcSEcCtD
Doxapram—Convulsion—Vincristine—lymphatic system cancer	0.00705	0.00705	CcSEcCtD
Doxapram—Cough—Mitoxantrone—lymphatic system cancer	0.00692	0.00692	CcSEcCtD
Doxapram—Convulsion—Mitoxantrone—lymphatic system cancer	0.00687	0.00687	CcSEcCtD
Doxapram—Headache—Fludarabine—lymphatic system cancer	0.00681	0.00681	CcSEcCtD
Doxapram—Chest pain—Mitoxantrone—lymphatic system cancer	0.00675	0.00675	CcSEcCtD
Doxapram—Anxiety—Mitoxantrone—lymphatic system cancer	0.00672	0.00672	CcSEcCtD
Doxapram—Nausea—Fludarabine—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Doxapram—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00642	0.00642	CcSEcCtD
Doxapram—Body temperature increased—Bleomycin—lymphatic system cancer	0.0063	0.0063	CcSEcCtD
Doxapram—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00625	0.00625	CcSEcCtD
Doxapram—Paraesthesia—Carmustine—lymphatic system cancer	0.00625	0.00625	CcSEcCtD
Doxapram—Dyspnoea—Carmustine—lymphatic system cancer	0.0062	0.0062	CcSEcCtD
Doxapram—Paraesthesia—Vincristine—lymphatic system cancer	0.00596	0.00596	CcSEcCtD
Doxapram—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00581	0.00581	CcSEcCtD
Doxapram—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Doxapram—Pruritus—Bleomycin—lymphatic system cancer	0.00564	0.00564	CcSEcCtD
Doxapram—Body temperature increased—Carmustine—lymphatic system cancer	0.0055	0.0055	CcSEcCtD
Doxapram—Body temperature increased—Vincristine—lymphatic system cancer	0.00525	0.00525	CcSEcCtD
Doxapram—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Doxapram—Sweating—Methotrexate—lymphatic system cancer	0.00484	0.00484	CcSEcCtD
Doxapram—Diarrhoea—Carmustine—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Doxapram—Nausea—Bleomycin—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Doxapram—Dizziness—Carmustine—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Doxapram—Diarrhoea—Vincristine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Doxapram—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00443	0.00443	CcSEcCtD
Doxapram—Dizziness—Vincristine—lymphatic system cancer	0.00439	0.00439	CcSEcCtD
Doxapram—Headache—Carmustine—lymphatic system cancer	0.00436	0.00436	CcSEcCtD
Doxapram—Headache—Vincristine—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Doxapram—Nausea—Carmustine—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Doxapram—Headache—Mitoxantrone—lymphatic system cancer	0.00405	0.00405	CcSEcCtD
Doxapram—Nausea—Vincristine—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Doxapram—Nausea—Mitoxantrone—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Doxapram—Leukopenia—Methotrexate—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Doxapram—Cough—Methotrexate—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Doxapram—Convulsion—Methotrexate—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Doxapram—Chest pain—Methotrexate—lymphatic system cancer	0.00336	0.00336	CcSEcCtD
Doxapram—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Doxapram—Paraesthesia—Methotrexate—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Doxapram—Dyspnoea—Methotrexate—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Doxapram—Body temperature increased—Methotrexate—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Doxapram—Pruritus—Methotrexate—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Doxapram—Diarrhoea—Methotrexate—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Doxapram—Dizziness—Methotrexate—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Doxapram—Headache—Methotrexate—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Doxapram—Nausea—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
